COVID-19 rapid guideline: managing COVID-19 [NG191], NICE (updated 4th October 2021)

This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use them more easily. On 4 October, we added new recommendations on casirivimab and imdevimab. New data on the use of heparins (from the REMAP-CAP trial results) does not change the current recommendations.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news